Form 4 for ELV Elevance Health
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001156039-22-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +36.5K | 122.3K | +43% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $452.66 | -17.0K | 85.8K | -17% | -$7.69M |
| D | 2022-03-03 | 2022-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +32.7K | 32.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 8,195 | $0.00 | 93,981 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 2,731 shares on 3/1/2023, and 2,732 shares each on 3/1/2024 and 3/1/2025. |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 28,303 | $0.00 | 122,284 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2022. |
| 3 | Common | Common Stock | 2022-03-02 | F | D | 1,645 | $463.49 | 120,639 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. (F4) Balance includes 226.50 shares acquired on March 25, 2021, 213.43 shares acquired on June 25, 2021, 214.36 shares acquired on September 24, 2021 and 184.20 shares acquired on December 21, 2021 through a dividend reinvestment plan. |
| 4 | Common | Common Stock | 2022-03-01 | F | D | 15,352 | $451.50 | 85,786 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-03-01 | A | A | 32,682 | $0.00 | 32,682 | D | $451.50 · — to 2032-03-01 | 32,682 Common Stock | (F5) The option represents a right to purchase a total of 32,682 shares, and is exercisable in three annual installments of 10,894 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date. |